Trial intelligence / Profile preview

Botulinum Toxin A for Post-Radiosurgical Neck Contractures

NCT02986880Phase 2Completed

Sponsor
Hôpital Foch
Start
Jun 2011
Primary completion
Jan 2014
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of botulinum toxin type A in cervical dystonia (CD) (10 arms), sponsored by Hôpital Foch. Primary endpoint: Cervical mobility degree at 6 months. Started Jun 2011; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

cervical dystonia (CD)

Beyond the preview

Go deeper on NCT02986880.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02986880.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call